Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Flaps | 11 | 2011 | 927 | 1.480 |
Why?
|
| Soft Tissue Injuries | 3 | 2011 | 51 | 1.000 |
Why?
|
| Thigh | 7 | 2010 | 172 | 0.810 |
Why?
|
| Trachea | 5 | 2013 | 259 | 0.740 |
Why?
|
| Extracellular Matrix | 5 | 2014 | 554 | 0.640 |
Why?
|
| Tissue Scaffolds | 7 | 2014 | 135 | 0.630 |
Why?
|
| Tissue Engineering | 7 | 2014 | 269 | 0.610 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2004 | 223 | 0.470 |
Why?
|
| Forefoot, Human | 1 | 2011 | 2 | 0.400 |
Why?
|
| Foot Injuries | 1 | 2011 | 13 | 0.400 |
Why?
|
| Adipose Tissue | 4 | 2014 | 769 | 0.370 |
Why?
|
| Mammaplasty | 3 | 2010 | 780 | 0.360 |
Why?
|
| Graft Rejection | 3 | 2013 | 834 | 0.350 |
Why?
|
| Face | 2 | 2010 | 273 | 0.350 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2008 | 48 | 0.310 |
Why?
|
| Tissue Transplantation | 1 | 2006 | 35 | 0.280 |
Why?
|
| Fascia | 3 | 2013 | 68 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2013 | 1533 | 0.270 |
Why?
|
| Ischemia | 1 | 2008 | 391 | 0.250 |
Why?
|
| Wounds and Injuries | 1 | 2008 | 399 | 0.240 |
Why?
|
| Transplantation, Heterologous | 1 | 2006 | 1082 | 0.240 |
Why?
|
| Silk | 2 | 2011 | 17 | 0.200 |
Why?
|
| Skin Transplantation | 3 | 2011 | 173 | 0.200 |
Why?
|
| Rats | 7 | 2013 | 6086 | 0.200 |
Why?
|
| Wound Healing | 4 | 2011 | 815 | 0.190 |
Why?
|
| Chitosan | 2 | 2011 | 79 | 0.190 |
Why?
|
| Genetic Therapy | 2 | 2004 | 1616 | 0.180 |
Why?
|
| Breast | 2 | 2002 | 1344 | 0.160 |
Why?
|
| Microscopy, Electron, Scanning | 3 | 2014 | 220 | 0.160 |
Why?
|
| Inflammation | 1 | 2008 | 2522 | 0.160 |
Why?
|
| Rats, Inbred F344 | 2 | 2013 | 224 | 0.140 |
Why?
|
| Graft Survival | 2 | 2010 | 1062 | 0.140 |
Why?
|
| Apoptosis | 1 | 2008 | 7591 | 0.120 |
Why?
|
| Regeneration | 2 | 2014 | 279 | 0.120 |
Why?
|
| Glycosaminoglycans | 1 | 2013 | 61 | 0.110 |
Why?
|
| Laminin | 1 | 2013 | 194 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 2063 | 0.110 |
Why?
|
| Male | 14 | 2013 | 123000 | 0.100 |
Why?
|
| Muscles | 1 | 2013 | 416 | 0.100 |
Why?
|
| Fibroins | 1 | 2011 | 20 | 0.100 |
Why?
|
| Acellular Dermis | 1 | 2012 | 103 | 0.100 |
Why?
|
| Animals | 11 | 2014 | 59536 | 0.100 |
Why?
|
| Cartilage | 1 | 2011 | 128 | 0.090 |
Why?
|
| Facial Hemiatrophy | 1 | 2010 | 5 | 0.090 |
Why?
|
| Collagen | 1 | 2013 | 752 | 0.090 |
Why?
|
| Popliteal Vein | 1 | 2008 | 9 | 0.080 |
Why?
|
| Transfection | 2 | 2004 | 2944 | 0.080 |
Why?
|
| Metalloproteases | 1 | 2008 | 24 | 0.080 |
Why?
|
| Esthetics | 1 | 2010 | 189 | 0.080 |
Why?
|
| Swine | 1 | 2013 | 1541 | 0.080 |
Why?
|
| Mesenteric Veins | 1 | 2008 | 73 | 0.080 |
Why?
|
| Angiography | 1 | 2009 | 360 | 0.080 |
Why?
|
| Cadaver | 1 | 2008 | 237 | 0.080 |
Why?
|
| Aneurysm | 1 | 2008 | 94 | 0.080 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 80 | 0.080 |
Why?
|
| Adolescent | 6 | 2010 | 31252 | 0.080 |
Why?
|
| Rabbits | 2 | 2011 | 957 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2008 | 367 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2008 | 429 | 0.070 |
Why?
|
| Acetylcysteine | 1 | 2008 | 143 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2008 | 471 | 0.070 |
Why?
|
| Female | 14 | 2014 | 141928 | 0.070 |
Why?
|
| Humans | 18 | 2014 | 261506 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2011 | 554 | 0.070 |
Why?
|
| Radiotherapy | 1 | 2014 | 1824 | 0.070 |
Why?
|
| Guinea Pigs | 1 | 2006 | 241 | 0.070 |
Why?
|
| Stem Cells | 1 | 2013 | 1213 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2014 | 1411 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 376 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2014 | 7226 | 0.070 |
Why?
|
| DNA Damage | 1 | 2014 | 1954 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 483 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 369 | 0.070 |
Why?
|
| Keloid | 1 | 2005 | 14 | 0.070 |
Why?
|
| Adult | 9 | 2010 | 77950 | 0.070 |
Why?
|
| Models, Animal | 1 | 2008 | 664 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 7548 | 0.060 |
Why?
|
| Eukaryotic Cells | 1 | 2004 | 45 | 0.060 |
Why?
|
| DNA | 1 | 2013 | 2693 | 0.060 |
Why?
|
| Neck Muscles | 1 | 2004 | 38 | 0.060 |
Why?
|
| Rats, Inbred Lew | 2 | 2013 | 113 | 0.060 |
Why?
|
| Cicatrix | 1 | 2005 | 208 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2004 | 869 | 0.060 |
Why?
|
| Rats, Nude | 2 | 2013 | 32 | 0.050 |
Why?
|
| Groin | 1 | 2002 | 74 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 837 | 0.050 |
Why?
|
| Chondrocytes | 2 | 2013 | 107 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2009 | 16273 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 1493 | 0.050 |
Why?
|
| Transplantation, Autologous | 1 | 2004 | 1914 | 0.040 |
Why?
|
| Child | 4 | 2009 | 29154 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2004 | 1694 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 2488 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 2927 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2005 | 1682 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2004 | 1203 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2008 | 2819 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2010 | 9244 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2010 | 6869 | 0.040 |
Why?
|
| Stem Cell Transplantation | 2 | 2013 | 1360 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 3552 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2014 | 4307 | 0.030 |
Why?
|
| Treatment Outcome | 4 | 2011 | 32848 | 0.030 |
Why?
|
| Genomics | 1 | 2005 | 2738 | 0.030 |
Why?
|
| Biomimetics | 1 | 2014 | 33 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 2013 | 34 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2013 | 17 | 0.030 |
Why?
|
| Freeze Drying | 1 | 2013 | 30 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 7551 | 0.030 |
Why?
|
| Foreign-Body Reaction | 1 | 2013 | 27 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2006 | 14889 | 0.030 |
Why?
|
| Middle Aged | 2 | 2011 | 86204 | 0.030 |
Why?
|
| Subcutaneous Tissue | 1 | 2013 | 62 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 128 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 550 | 0.030 |
Why?
|
| Aged | 2 | 2009 | 70117 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 15694 | 0.030 |
Why?
|
| Emodin | 1 | 2011 | 14 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2011 | 73 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2014 | 1008 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 21445 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 206 | 0.020 |
Why?
|
| Chondrogenesis | 1 | 2011 | 67 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 2012 | 167 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 1519 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2012 | 5637 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 769 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 11965 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 2314 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2008 | 25 | 0.020 |
Why?
|
| Quinazolines | 1 | 2014 | 923 | 0.020 |
Why?
|
| Phlebography | 1 | 2008 | 76 | 0.020 |
Why?
|
| Varicose Veins | 1 | 2008 | 35 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2008 | 100 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2008 | 95 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 256 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 3045 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 15193 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 14551 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 2843 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2010 | 37905 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 360 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 1581 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 1304 | 0.020 |
Why?
|
| Medical Records | 1 | 2008 | 415 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 2218 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 2466 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2013 | 1818 | 0.020 |
Why?
|
| Leg Ulcer | 1 | 2005 | 24 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 116 | 0.020 |
Why?
|
| Clavicle | 1 | 2002 | 65 | 0.010 |
Why?
|
| Pectoralis Muscles | 1 | 2002 | 27 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3821 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2008 | 655 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 2450 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2005 | 291 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 2803 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 3869 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 4078 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 14289 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2508 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 2292 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 3570 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 6150 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 5159 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 34495 | 0.010 |
Why?
|